Carolina BioOncology Institute, PLLC

Huntersville, North Carolina 28078

1 studies enrolling now · 9 studies all time

What they study most

Advanced Cancer, Advanced Malignancies, Advanced Solid Tumors, Carcinoma, Non-Small-Cell Lung, Colorectal Cancer, Gastrointestinal (GI) Malignancies, Hodgkin's Disease, Locally Advanced Solid Tumors, Malignant Melanoma, Metastatic Solid Tumors, Prostate Cancer, Renal Cancer

Studies at this site

• First In Human Study of CX-2051 in Advanced Solid Tumors — Recruiting now
• Study of INCB123667 in Subjects With Advanced Solid Tumors — Running, not enrolling
• Study of INCA 0186 in Subjects With Advanced Solid Tumors — Stopped early
• A Phase 1 Study of INCMGA00012 in Patients With Advanced Solid Tumors — Completed
• A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors — Completed
• A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723) — Completed
• A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1 — Completed
• A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease — Completed
• A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies — Completed